Joel is a Partner at TPG Capital and leads the firm’s investment program in the ANZ region as Head of Australia and New Zealand. Joel has previously served on the board of Inghams Group Limited and Accolade Wines Holding Australia Pty Limited.

Before joining TPG, Joel was a director at CPE Capital (formerly known as CHAMP Private Equity) where he was responsible for the company’s activities in the industrial, agricultural services and consumer markets.

Vincent Wong is a Managing Director with TPG Capital and is based in Melbourne, where he works in TPG’s Australian team. Prior to joining TPG in 2011, Vincent served in the corporate advisory division at Goldman Sachs Australia. Vincent graduated from the University of Melbourne with BCommerce and BLaws (Honors).

Lydia Cai is a Managing Director with TPG Capital based in Beijing and leads TPG’s healthcare investments in the Greater China area. Prior to joining TPG in 2011, Lydia was an investment associate at HAO Capital, a China-focused early stage private equity fund focusing on growth-stage healthcare investments.

Dr. Phua is responsible for providing independent advice to the Board. Dr. Phua chairs the Remuneration Committee, and is a member of the Audit Committee and the Nomination Committee. Dr. Phua spent more than 30 years in the pharmaceutical and healthcare industry. Dr. Phua received his medical degree from the University of Singapore in May 1978 and a master of science in human nutrition from the University of Bridgeport in the United States in May 2011.

Ms. Cheung is responsible for providing independent advice to the Board. She chairs the Audit Committee and is a member of the Remuneration Committee and the Nomination Committee. Ms. Cheung has more than 30 years of corporate experience in the Asia-Pacific region. In January 1990, Ms. Cheung graduated from San Francisco State University with a bachelor of science degree, majoring in business administration.